Synthetic switches of OGG1 control initiation of base excision repair and offer new treatment strategies

• Carlos Benitéz‐Buelga,
• Thomas Helleday,
• Maurice Michel

Affiliations

Carlos Benitéz‐Buelga

Instituto de Investigaciones Biomédicas Alberto Sols (CSIC/UAM) Madrid Spain

Thomas Helleday

Sheffield Cancer Centre, Department of Oncology and Metabolism University of Sheffield Sheffield UK

Maurice Michel

Science for Life Laboratory, Department of Oncology‐Pathology Karolinska Institute Stockholm Sweden